DGAP-Adhoc: Schwarz Pharma AG: Start of Squeeze Out

SCHWARZ PHARMA AG / Squeeze Out

06.02.2009 

Release of a Adhoc News, transmitted by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------

Ad-hoc announcement pursuant to section 15 of the German Securities Trading
Act (WpHG)

Start of Squeeze Out Proceedings

UCB SP GmbH, Monheim, today notified SCHWARZ PHARMA AG 's Executive Board
of its formal request pursuant to section 327a of the German Stock
Corporation Act (AktG), that the General Meeting of the company may resolve
the transfer of the outstanding shares held by the other
shareholders(minority shareholders) to UCB SP GmbH as the principal
shareholder in return for an adequate cash compensation (so called 'squeeze
out'). UCB SP GmbH holds  99.59% of SCHWARZ PHARMA AG's share capital
(excluding treasury shares) and is, thus, the principal shareholder within
the meaning of section 327a (1) sentence (1) AktG. The resolution may be
adopted at SCHWARZ PHARMA AG's next Annual General Meeting for the
financial year 2008 which is scheduled for July 8, 2009.

Monheim, February 6, 2009

The Executive Board

SCHWARZ PHARMA Aktiengesellschaft

Alfred-Nobel-Str. 10

40789 Monheim

Germany

Investor Relations:

Sylvia Heitzer, Tel: +49 2173 48 1238

ISIN: DE0007221905

WKN: 722190

Listed: Regulierter Markt in Frankfurt (General Standard)

End of News



Contact:
Investor Relations: 
Sylvia Heitzer, Tel: +49 2173 48 1238; 



DGAP 06.02.2009 
---------------------------------------------------------------------------
Language:     English
Issuer:       SCHWARZ PHARMA AG
              Alfred-Nobel-Str. 10
              40789 Monheim
              Deutschland
Phone:        +49 2173 48 1866
Fax:          +49 2173 48 1856
E-mail:       antje.witte@schwarzpharma.com
Internet:     www.schwarzpharma.com
ISIN:         DE0007221905
WKN:          722190
Listed:       Regulierter Markt in Frankfurt (General Standard),
              Düsseldorf; Freiverkehr in Berlin, Hannover, München,
              Hamburg, Stuttgart
End of News                                     DGAP News-Service
---------------------------------------------------------------------------
DGAP-Adhoc: Schwarz Pharma AG: Start of Squeeze Out Proceedings
